Sen. Michael Dembrow

Establishes Home Weatherization, Retrofit and Affordability Program for Housing and Community Services Department to provide incentive payments to construction contractors undertaking energy improvement projects on residential structures. Requires contractors to reduce property owners' costs by amount of incentive payments received. Reserves moneys for activities promoting healthy, affordable housing environments. Authorizes department to enter into agreements with other units of state government to operate home weatherization programs. Limits program expenditures. Sunsets program January 2, 2023. Takes effect on 91st day following adjournment sine die.

Establishes TriMet Crash Advisory Committee. Provides that committee shall review certain crashes involving TriMet vehicles that result in injury or fatality. Requires committee to assess causes of such crashes, make recommendations to prevent similar crashes and submit quarterly report on findings to Transportation Safety Committee. Requires TriMet to provide meeting space and staff support to TriMet Crash Advisory Committee.

Directs Department of Human Services to provide reimbursements for transportation expenses incurred on behalf of foster child if expenses are related to child's continuing participation in extracurricular activities child engaged in prior to child's placement in foster home or child-caring agency.

Designates April of each year as Arab-American Heritage Month.

Allows Oregon Liquor Control Commission to enter into interstate agreements with agencies of other states for purpose of ensuring multistate enforcement of standards for wine consistent with standards of state where wine was produced.

Allows pharmacist or pharmacy technician to transfer drug containing pseudoephedrine without prescription to person who is at least 18 years of age and presents person's valid government-issued photo identification. Requires pharmacist or pharmacy technician, prior to transfer, to submit specified information into electronic system designed to prevent illegal transfer of drugs containing pseudoephedrine. Requires pharmacist or pharmacy technician to record specified information about transfer of drug containing pseudoephedrine. Specifies maximum amount of pseudoephedrine that person may receive without prescription. Establishes storage requirements for drug containing pseudoephedrine. Clarifies that measure does not apply to drugs transferred pursuant to prescription. Punishes violation by 364 days' imprisonment, $6,250 fine, or both. ] Allows pharmacist to prescribe and dispense pseudoephedrine to person who is at least 18 years of age and who provides to pharmacist person's valid government-issued photo identification. Requires pharmacist to query prescription monitoring program prior to prescription and dispensation. Limits amount of pseudoephedrine person may receive. Allows State Board of Pharmacy to adopt rules. Removes provision subjecting records of specified transactions to inspection by board and law enforcement agencies. Becomes operative January 1, 2020. Sunsets December 31, 2023. ] Takes effect on 91st day following adjournment sine die.

Appropriates moneys to Oregon Department of Administrative Services to increase size and diversity of group of court appointed special advocates.

Disallows, for purposes of personal income taxation, mortgage interest deduction for residence other than taxpayer's principal residence , unless taxpayer sells residence or actively markets residence for sale . Phases out allowable deduction for interest for principal residence based upon income. Disallows deduction for principal residence above threshold amount. Establishes Oregon Housing Opportunity Account. Transfers amount equal to estimated increase in revenue attributable to restrictions on deduction of mortgage interest to accounts in Oregon Housing Fund ] account . Applies to tax years beginning on or after January 1, 2019. Takes effect on 91st day following adjournment sine die.

Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services total cost of ] amount of money spent on patient assistance programs , and ] information on financial assistance provided to pharmacies, government agencies and advocacy organizations and total amount of financial incentives paid to each pharmacy benefit manager . Excludes proprietary information from disclosure on department's website. ] Exempts from public disclosure information reported to department until department posts to website all information reported by manufacturer. Requires state-sponsored programs that use pharmacy benefit managers to use fee-only pharmacy benefit managers. Requires insurers to post specified information regarding formulary, tiers and costs for small employer and individual health benefit plans to insurer's website. Requires 60-day advance notice to department and to enrollees adversely affected by change in formulary. Requires insurer and allows pharmacy to notify insured that if cash ] retail price for drug is less than insured's cost-share ] out-of-pocket cost for drug using pharmacy benefit , insured may pay cash ] retail price and expense must be counted ] if requested by enrollee, insurer must count cost toward deductible or out-of-pocket maximum. Requires State Board of Pharmacy to prescribe by rule notice of enrollee's rights for distribution to pharmacy customers and to translate notice into multiple languages. Requires hospitals and other medical providers to disclose in patient billing information regarding mark-up on price of drug. Also requires billing to disclose price of drug charged to specified state agencies and insurers ] report to Oregon Health Authority information regarding 50 most prescribed drugs and 50 most expensive drugs prescribed by provider . Requires specified state agencies to report to Legislative Assembly on high-cost drugs. Requires Oregon Health Authority to refer to Pharmacy and Therapeutics Committee any drug exceeding specified cost. Requires patient advocacy organization with budget ] annual gross receipts exceeding $50,000 that has registered lobbyist in this state to report to Oregon Government Ethics Commission and Oregon Health Authority ] specified information regarding funding received from participants in pharmaceutical supply chain. Requires pharmacy benefit managers to report to Department of Consumer and Business Services and plan sponsors specified information regarding rebates, reimbursements, fees and incentives paid for drugs by manufacturers, insurers and pharmacies. Requires insurers to include with rate filing certified statement regarding insurers' use of rebates. Requires drug advertisement to disclose wholesale price of drug. ] Modifies responsibilities of Task Force on Fair Pricing of Prescription Drugs and requires report of findings, by September 15, 2020, to interim committees of Legislative Assembly related to health. Modifies reporting to department by insurers about costly drugs reimbursed by health benefit plans. Requires pharmaceutical manufacturers that register with State Board of Pharmacy to also register with department. Requires department to adopt registration fee based on reasonable cost to department to administer specified provisions.

Modifies juvenile code to prohibit placement of children and wards taken into protective custody in detention facilities. Declares emergency, effective on passage.